Clinical Trials Browser

Neoplasm Metastasis, Endometrial Neoplasms

Carcinoma, Non-Small-Cell Lung

Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Unspecified Adult Solid Tumor, Protocol Specific

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Breast Neoplasms, Ovarian Neoplasms, Recurrence

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

Glioblastoma

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence, Disease Progression

Brain Neoplasms, Glioblastoma

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms, Neoplasm Metastasis

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Solid Tumors

Breast Neoplasms

Lung Neoplasms, Hereditary Sensory and Autonomic Neuropathies

Extensive Stage Small Cell Lung Cancer

Lymphoma, Recurrence

Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

Solid Tumors

Breast Neoplasms

Colorectal Neoplasms

Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Breast Neoplasms, Neoplasms

Clinical Trials

ENDOPIK

BKM120

A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma

PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic

Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma

Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer

A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

PIK-ORL

Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib

BKM120 For Triple Negative Breast Cancer

Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors

PIKTAM

A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies

Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer

Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)

BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer

BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors

BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer

A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer

Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias

PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer

PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer

Pharmacodynamic Study of BKM120 in Breast Cancer